• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Hemagen Diagnostics Inc

+ Add to Watchlist

HMGN:US

0.0150 USD 0.0010 6.25%

As of 20:10:00 ET on 08/26/2014.

Snapshot for Hemagen Diagnostics Inc (HMGN)

Open: 0.0150 Day's Range: 0.0150 - 0.0150 Volume: 1,000
Previous Close: 0.0160 52wk Range: 0.0066 - 0.0582 1-Yr Rtn: -62.50%

Stock Chart for HMGN

No chart data available.
  • HMGN:US 0.0150
  • 1D
  • 1M
  • 1Y
0.0160
Interactive HMGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HMGN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0600
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.23
Shares Outstanding (M) 15.50
30 Day Average Volume 5,811
Price/Book (mrq) -
Price/Sale (ttm) 0.0575
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HMGN

No data available

Company Profile & Key Executives for HMGN

Hemagen Diagnostics, Inc. develops, manufactures, and markets proprietary medical diagnostic test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company also manufactures and markets a line of clinical chemistry reagents, and the Analyst and Endocheck clinical chemistry analyzers. Hemagen sells its products in the United States and internationally.

William P HalesChairman/President/CEORobert CampbellChief Financial Officer
Catherine M DavidsonController
More Company Profile & Key Executives for HMGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • HMGN News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil